Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cell Therapeutics names new board member

This article was originally published in Scrip

Executive Summary

Seattle, US-based Cell Therapeutics, a biopharmaceutical company developing a portfolio of oncology products, has named Karen Ignagni to its board of directors – effective from 3 February 2014. Ms Ignagni currently serves as president and CEO of America's Health Insurance Plans (AHIP), the trade association representing US health plans. She also currently sits on the boards of the National Quality Forum, the National Advisory Committee for Altarum Institute's Center for Sustainable Health Spending, and the Healthcare Financial Management Association's Leadership Council.

You may also be interested in...



Snapshot: April Highlights

A selection of articles you might have missed from April 2022, including exclusive interviews, an in depth look at the impact of COVID-19 on clinical trial trends, and the latest Rising Leaders series. 

Transforming Patient Engagement At Novartis

Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action. 

In Vivo's 2022 Rising Leaders At A Glance

Top 30 Leaders: see the list of entrepreneurs and innovators highlighted in the third edition of In Vivo's Rising Leaders series. 

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC024348

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel